ResMed (NYSE: RMD, ASX: RMD), a leader in cloud-connected medical
devices and out-of-hospital SaaS solutions, today announced it has
elected experienced business executive Jan De Witte to its board of
directors.
Mr. De Witte was appointed during ResMed’s regularly scheduled board
meeting on May 16, 2019, to fill a newly created directorship, effective
immediately. Also at that meeting, Jack Wareham announced he intends to
retire from ResMed’s board after serving since January 2005. Mr.
Wareham’s resignation will be effective at ResMed’s November 2019 annual
stockholders meeting.
De Witte has more than 30 years’ experience in health and technology
products as an executive and business leader in the United States and
Europe. He is currently CEO and board member of Barco NV., positions he
has held since 2016. Barco, a global technology company, designs and
develops visualization and collaboration technology solutions for the
healthcare, enterprise, and entertainment markets.
Before joining Barco as CEO, De Witte was president and CEO of General
Electric’s Global Healthcare IT business, a $1.6 billion revenue
business with more than 4,500 employees worldwide that provides software
solutions to healthcare providers. This position capped a 17-year career
with General Electric’s healthcare business, based in the United States
and France.
Before General Electric, De Witte worked at McKinsey & Company Inc. from
1993 to 1998 in Brussels, Amsterdam, and Zurich, serving clients in the
industrial and transportation sector on strategy and business
development, business process re-engineering and operational
improvement. From 1987 to 1991, he worked at the Procter & Gamble
Company in Belgium in various production planning, logistics, and supply
chain roles.
De Witte holds a Master’s degree in electromechanical engineering from
the Katholieke Universiteit Leuven in Belgium, and an MBA from Harvard
University in Cambridge, Mass.
“I’m pleased to welcome Jan De Witte to ResMed’s Board,” said ResMed
Founder and Board Chairman Peter Farrell. “His perspective as CEO of a
global technology company, coupled with his three decades of healthcare
and technology experience, will benefit ResMed as it continues its
global leadership in connected medical devices and out-of-hospital
software.”
“I’d also like to thank Jack Wareham for his insights and circumspect
guidance to ResMed over the past 14 years of service as a director,”
said Farrell. “Jack’s experience as CEO of Beckman Coulter gave him the
background to provide exceptionally wise counsel to the board and
management.”
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that
treat and keep people out of the hospital, empowering them to live
healthier, higher-quality lives. Our cloud-connected medical devices
transform care for people with sleep apnea, COPD and other chronic
diseases. Our comprehensive out-of-hospital software platforms support
the professionals and caregivers who help people stay healthy in the
home or care setting of their choice. By enabling better care, we
improve quality of life, reduce the impact of chronic disease and lower
costs for consumers and healthcare systems in more than 120
countries. To learn more, visit ResMed.com and follow @ResMed.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190516006016/en/